01 3Sancuso
Granisetron Transdermal System
Main Therapeutic Indication : Anti-emetic
Currency : USD
2017 Revenue in Millions : 29
2016 Revenue in Millions : 30
Growth (%) : -3
Granisetron Transdermal System
Main Therapeutic Indication : Anti-Emetic
Currency : USD
2018 Revenue in Millions : 27
2017 Revenue in Millions : 27
Growth (%) : 0%
Granisetron Transdermal System
Main Therapeutic Indication : Anti-Emetic
Currency : USD
2019 Revenue in Millions : 27
2018 Revenue in Millions : 28
Growth (%) : -3
LOOKING FOR A SUPPLIER?